Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments

Skin Pharmacology and Physiology

Volumn 21, Issue 2, 2008, Pages 81-88

  Henning, A ^a   Neumann, D ^b   Kostka, K H ^c   Lehr, C M ^a   Schaefer, U F ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Center for Bioinformatics   (Germany)

^c Caritaskrankenhaus ^*  (Germany)

Author keywords

Diffusion resistance; Flufenamic acid; Human skin; Hydrophilic and lipophilic donor; In vitro permeation experiments; Preparation techniques

Indexed keywords

FLUFENAMIC ACID;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DERMIS; DRUG PENETRATION; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKIN GRAFT; SKIN PENETRATION; STRATUM CORNEUM;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; EPIDERMIS; FEMALE; FLUFENAMIC ACID; HUMANS; MODELS, BIOLOGICAL; PERMEABILITY; SKIN; SOLUBILITY; SPECIMEN HANDLING; VEHICLES;

EID: 41149143036     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112958     Document Type: Article

References (30)

1. Flynn GL: Physicochemical determinants of skin absorption; in Gerrity TT, Henry CJ (eds): Principles of Route to Route Extrapolation for Risk Assessment. New York, Elsevier Science, 1990, pp 93-127.
2. Organization for Economic Cooperation and Development (OECD): Guidance document for the conduct of skin absorption studies, No 28. Guidelines for the Testing of Chemicals. Paris, OECD, May 2002, vol 1, No 5, pp 1-31.
3. Stringer DA (ed): Percutaneous Absorption. Monograph No 20. Brussels, European Centre for Ecotoxicology and Toxicology of Chemicals, 1993.
4. Scientific Committee on Cosmetic and Non-Food Products (SCCNFP): Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. Brussels, SCCNFP, 2003.
5. Bronaugh RL: In vitro diffusion cell studies; in Riviere JE (ed): Dermal Absorption Models in Toxicology and Pharmacology. Boca Raton, Taylor & Francis Group, 2005, pp 21-27.
6. Chilcott RP, Barai N, Beezer AE, Brain SI, Brown MB, Bunge AL, Burgess SE, Cross S, Dalton CH, Dias M, Farinha A, Finnin BC, Gallagher SJ, Green DM, Gunt H, Gwyther RL, Heard CM, Jarvis CA, Kamiyama F, Kasting GB, Ley EE, Lim ST, McNaughton GS, Morris A, Nazemi MH, Pellett MA, Du Plessis J, Quan YS, Raghavan SL, Roberts M, Romonchuk W, Roper CS, Schenk D, Simonsen L, Simpson A, Traversa BD, Trottet L, Watkinson A, Wilkinson SC, Williams FM, Yamamoto A, Hadgraft J: Inter- and intra-laboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci 2005;94:632-638.
7. Southwell D, Barry BW, Woodford R: Variations in permeability of human skin within and between specimens. Int J Pharm 1984;18:299-309.
8. Schaefer-Korting M, Bock U, Gamer A, Haberland A, Haltner-Ukomadu E, Kaca M, Kamp H, Kietzmann M, Korting HC, Krachter HU, Lehr CM, Liebsch M, Mehling A, Netzlaff F, Niedorf F, Rubbelke MK, Schaefer UF, Schmidt E , Schreiber S , Schroder KR, Spielmann H, Vuia A: Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. Altern Lab Anim 2006;34:283-294.
9. US EPA, Dermal Exposure Assessment: Principles and Applications. Washington, Exposure Assessment Group, Office of Health and Environmental Assessment, 1992.
10. Bronaugh RL, Wester RC, Bucks D, Maibach HI, Sarason R: In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans. Food Chem Toxicol 1990;28:369-373.
11. Feldmann RJ, Maibach HI: Absorption of some organic compounds through the skin in man. J Invest Dermatol 1970;54:399-404.
12. Wagner H, Kostka KH, Lehr CM, Schäfer UF: Human skin penetration of flufenamic acid: in-vivo/in-vitro correlation (deeper skin layers) for skin samples from the same subject, J Invest Dermatol 2002;118:540-544.
13. Moser K, Kriwet K, Naik A, Kalia YN, Guy RH: Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 2001;52:103-112.
14. Franz TJ: On the relevance of in vitro data. J Invest Dermatol 1975;64:190-195.
15. Harrison SM, Barry BW, Dugard PH: Effects of freezing on human skin permeability. J Pharm Pharmacol 1984;36:261-262.
16. Schaefer U, Loth H: An ex-vivo model for the study of drug penetration into human skin. Pharm Res 1996;13(suppl):366.
17. Kligman AM, Christophers E: Preparation of isolated sheets of human stratum corneum. Arch Dermatol 1963;88:702-705.
18. Aguiar AJ, Fifelski RJ: Effect of pH on the in vitro absorption of flufenamic acid. J Pharm Sci 1966;55:1387-1391.
19. Terada H, Muraoka S, Fujita T: Structure-activity relationships of fenamic acids. J Med Chem 1974;17:330-334.
20. Wagner H, Kostka KH, Lehr CM, Schaefer UF: Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data. Pharm Res 2000;17:1475-1481.
21. Wagner H, Kostka KH, Lehr CM, Schaefer UF: Interrelation of permeation and penetration parameters obtained from in-vitro experiments with human skin and skin equivalents. J Control Release 2001;75:283-295.
22. Organization for Economic Cooperation and Development (OECD): Skin absorption: in vitro method, test guideline No 428. Guidelines for the Testing of Chemicals. Paris, OECD, August 2006, vol 1, No 4, pp 1-8(8).
23. Netzlaff F, Kostka KH, Lehr CM, Schaefer UF: TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro: limitations shown by transport data testing. Eur J Pharm Biopharm 2006;63:44-50.
24. Harrison JE, Watkinson AC, Green DM, Hadgraft J, Brain K: The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm Res 1996;13:542-546.
25. Cordero JA, Alarcon L, Escribano E, Obach R, Domenech J: A comparative study of the transdermal penetration of a series of non-steroidal antiinflammatory drugs. J Pharm Sci 1997;86:503-508.
26. Lockley DJ, Howes D, Williams FM: Percutaneous penetration and metabolism of 2-butoxyethanol. Arch Toxicol 2004;78:617-628.
27. Bronaugh RL, Stewart RF, Simon M: Methods for in-vitro percutaneous absorption studies. VII. Use of excised human skin. J Pharm Sci 1986;75:1094-1097.
28. Barrer RM, Barrie JA, Rogers MG: Permeation through a membrane with mixed boundary conditions. Trans Faraday Soc 1962;58:2473-2483.
29. Netzlaff F, Kaca M, Bock U, Haltner-Ukomadu E, Meiers P, Lehr C-M, Schaefer UF: Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations. Eur J Pharm Biopharm 2007;66:127-134. DOI: 10.1016/j.ejpb.2006.08.012.
30. Elias PM, Cooper ER, Korc A, Brown BE: Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 1989;76:297-301.